Measures metabolites in blood and tissue samples from people with melanoma
Compares metabolite patterns in samples from adults with skin melanoma and healthy people.
Plain-language title generated from the registry record
Registry title: The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
Key facts
- Where
- Dresden, GermanySee the site
Where in Germany
- University Hospital Carl Gustav CarusDresden, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Technische Universität Dresden
- Trial code
- NCT06765850
- Record updated
- 9 January 2025
- Original description
Prospective, single-centre study with the central question of how the metabolome from blood samples, different body fluids and tissues between patients patients with malignant melanoma in different tumour tumour stages and healthy patients and whether this is suitable for early detection of initial diagnosis, recurrence or stage shift at an early stage.Read full original descriptionShow less
Measurement of the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography.
Prospective, single-centre study with the central question of how the metabolome from blood samples, different body fluids and tissues between patients patients with malignant melanoma in different tumour tumour stages and healthy patients and whether this is suitable for early detection of initial diagnosis, recurrence or stage shift at an early stage.
The biosamples are collected in the BioBank Dresden and used for the NMR and LC-MS analyses described here. It is planned to use the biosamples for further analyses.
Inclusion: Current or past history of melanoma; Ongoing therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital.
Exclusion: Refusal to participate in the study; Lack of capacity to consent.